Pioneering cellular medicines for women’s health

We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

Eradicate Cancer Conference POSTPONED

By Christine Filippis / March 10, 2020
The increasing number of travel bans instigated by universities, hospitals and businesses caused by COVID 19 fears has unfortunately left...
Read More

Cartherics makes homework fun

By Christine Filippis / March 2, 2020
Research Fellow Nicholas Boyd shows the lab to the Fitzroy Homework Club. It was a big pleasure to be involved...
Read More